Ruben Abagyan
Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego
Ruben Abagyan is listed as Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego. B2DB records 2 sessions at 1 conference in 2026, most recently Drug Discovery Chemistry Europe 2026 (November 2026). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Ruben. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
About
Dr. Ruben Abagyan is a Professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego, which he joined in 2009. He received his Master’s and Ph.D. degrees in molecular physics at MPTI and MSU. At the European Molecular Biology Laboratory in Heidelberg he developed internal coordinate mechanics and structural docking approach (ICM) for modeling and docking. He received his tenure at New York University and Courant Institute of Mathematics and continued at the Novartis Institute and the Scripps Research Institute in La Jolla, California. Dr. Abagyan serves on international review panels for Institutes in Switzerland, UK, EU, and Hong Kong. He received CapCure awards, Princess Diana Award and medal in Sydney, Australia, American Association of Colleges of Pharmacy Teacher of the Year award, and UCSD-SSPPS 'Faculty of the Year' awards. R.A. authored and co-authored 340 research papers and book chapters, with over 40,000 citations and H-ind
Sessions at 1 conference
Drug Discovery Chemistry Europe 2026 11 November 2026 – 12 November 2026
- Accurate Docking Meets AI/ML Tools to Walk through Vast Chemical Spaces: From Idea to Clinic Speaker · 10 November 2026
- AI/ML- True Impact in Drug Discovery Today Moderator · 10 November 2026
Spoke alongside
People who have shared a session with Ruben at events on B2DB.
- Ashwini Ghogare GenAI Leader for Start-ups, Life Sciences and Healthcare · Amazon Web Services 1 shared session
- Steven Crossan CEO & Founder · Dayhoff Labs 1 shared session
- Aleksandra Karolak Assistant Professor · Moffitt Cancer Center 1 shared session
- Arvind Rao Professor of Computational Medicine and Bioinformatics, Radiation Oncology · University of Michigan 1 shared session